Anticoagulation TAKE COURSE NOW
External CPD Credits: 3
GMS Study Leave: 1/2 day
No of Lessons: 4
Certificate of Completion
TAKE COURSE NOW
Overview of Module
This Module was supported by an unrestricted educational grant from Pfizer Ireland :
Lesson 1: Initiating Warfarin TherapyThe Medicines Management Programme (MMP) in Ireland recommends warfarin as 'the agent of choice and the first-line anticoagulant, for most patients with atrial fibrillation', and it is increasingly prescribed and monitored in general practice. This lesson outlines current guidance around assessment prior to initiation of warfarin therapy.
Lesson 2: Ongoing Monitoring & Management of Warfarin TherapyThis lesson focuses on initiation & management of Warfarin therapy, and particularly on monitoring target INR (International Normalized Ratio) and TTR (time in therapeutic range).
Lesson 3: About Novel Oral Anticoagulants (NOACs)The arrival on the market of 3 new or novel oral anticoagulants or NOACs, expanded the pharmacological options for conditions needing anticoagulation. This lesson discusses the risk-benefit of NOACs versus warfarin.
Lesson 4: Prescribing & Monitoring Novel Oral Anticoagulants (NOACs)This lesson outlines issues and assessments which should be discussed & undertaken in all patients, both prior to commencement of a NOAC, and during follow-up.
NOTE: While a number of ICGP modules have a tight focus on one or two domains, most modules endeavour to address all domains to some degree (low, medium, high). This is clearly displayed in the diagram below
Technical problems and registration issues will be addressed by contacting
For content-related queries, please contact
ICGP Contact Details:
Administrator: Yvette Dalton email@example.com
For members of the public wishing to learn about Anticoagulants we suggest you talk with your local GP or visit